Dean Investment Associates LLC maintained its position in CVS Health Corp (NYSE:CVS) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 84,910 shares of the pharmacy operator’s stock at the end of the second quarter. CVS Health makes up about 1.1% of Dean Investment Associates LLC’s investment portfolio, making the stock its 13th biggest position. Dean Investment Associates LLC’s holdings in CVS Health were worth $6,665,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CVS. Boston Partners raised its holdings in CVS Health by 69.1% in the second quarter. Boston Partners now owns 6,459,237 shares of the pharmacy operator’s stock valued at $519,711,000 after acquiring an additional 2,638,888 shares in the last quarter. Prudential Financial Inc. increased its stake in CVS Health by 61.8% in the second quarter. Prudential Financial Inc. now owns 2,946,531 shares of the pharmacy operator’s stock valued at $237,078,000 after purchasing an additional 1,125,400 shares during the last quarter. Canada Pension Plan Investment Board increased its stake in CVS Health by 89.8% in the second quarter. Canada Pension Plan Investment Board now owns 1,851,099 shares of the pharmacy operator’s stock valued at $148,939,000 after purchasing an additional 876,027 shares during the last quarter. Veritas Asset Management LLP increased its stake in CVS Health by 11.4% in the second quarter. Veritas Asset Management LLP now owns 8,438,564 shares of the pharmacy operator’s stock valued at $678,967,000 after purchasing an additional 865,756 shares during the last quarter. Finally, NN Investment Partners Holdings N.V. increased its stake in CVS Health by 141.2% in the second quarter. NN Investment Partners Holdings N.V. now owns 1,427,210 shares of the pharmacy operator’s stock valued at $114,832,000 after purchasing an additional 835,476 shares during the last quarter. 81.42% of the stock is currently owned by institutional investors.

CVS Health Corp (NYSE:CVS) opened at $70.55 on Monday. The company has a current ratio of 1.05, a quick ratio of 0.55 and a debt-to-equity ratio of 0.67. The stock has a market cap of $71,466.59, a P/E ratio of 12.36, a PEG ratio of 1.21 and a beta of 0.86. CVS Health Corp has a 1 year low of $66.45 and a 1 year high of $84.72.

CVS Health (NYSE:CVS) last announced its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.01. The business had revenue of $46.18 billion for the quarter, compared to analyst estimates of $46.17 billion. CVS Health had a net margin of 2.78% and a return on equity of 14.90%. The company’s revenue for the quarter was up 3.5% compared to the same quarter last year. During the same period last year, the firm posted $1.64 earnings per share. research analysts predict that CVS Health Corp will post 5.9 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, November 3rd. Stockholders of record on Tuesday, October 24th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, October 23rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.83%. CVS Health’s dividend payout ratio (DPR) is presently 41.32%.

In related news, EVP Thomas M. Moriarty sold 90,267 shares of the stock in a transaction on Monday, September 11th. The stock was sold at an average price of $79.61, for a total transaction of $7,186,155.87. Following the completion of the sale, the executive vice president now directly owns 70,102 shares of the company’s stock, valued at $5,580,820.22. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Thomas M. Moriarty sold 20,547 shares of the stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $81.17, for a total value of $1,667,799.99. Following the sale, the executive vice president now directly owns 43,178 shares of the company’s stock, valued at $3,504,758.26. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 714,125 shares of company stock worth $58,119,381. Insiders own 0.61% of the company’s stock.

Several equities analysts have commented on the stock. Royal Bank Of Canada assumed coverage on shares of CVS Health in a research note on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 price target on the stock. Jefferies Group LLC increased their price target on shares of CVS Health from $82.00 to $86.00 and gave the company a “hold” rating in a research note on Friday, September 15th. BidaskClub upgraded shares of CVS Health from a “sell” rating to a “hold” rating in a research note on Wednesday, August 2nd. Needham & Company LLC reiterated a “hold” rating on shares of CVS Health in a research note on Sunday, September 10th. Finally, Wolfe Research lowered shares of CVS Health from an “outperform” rating to a “market perform” rating and dropped their price target for the company from $89.00 to $82.00 in a research note on Monday, August 14th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $85.82.

ILLEGAL ACTIVITY WARNING: “CVS Health Corp (CVS) Position Held by Dean Investment Associates LLC” was first published by Watch List News and is the property of of Watch List News. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at https://www.watchlistnews.com/cvs-health-corp-cvs-position-held-by-dean-investment-associates-llc/1728986.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.